1 documents found
Information × Registration Number 0212U000574, 0110U001818 , R & D reports Title Development a personalized correction hypertension with insulin resistance based on molecular genetic analysis and ATR2R1 and PPARgamma genes polymorphisms popup.stage_title Head Babak Oleg Yakovich, Registration Date 27-02-2012 Organization 3.Kharkov national medical university popup.description2 The dependence of the severity of hypertension with insulin resistance on gene polymorphisms ATR2R1 and PPARgamma. Created therapeutic strategy for the telmisartan and pioglitazone as a function of the identified genotypes. Product Description popup.authors Біловол А.М. Железнякова Н.М. Кліменко Н.М. Лісова Г.В. Молодан В.І. Молодан Д.В. Просоленко К.О. Фадєєнко Г.Д. Школьнік В.В. Ярмиш Н.В. popup.nrat_date 2020-04-02 Close
R & D report
Development a personalized correction hypertension with insulin resistance based on molecular genetic analysis and ATR2R1 and PPARgamma genes polymorphisms
Head: Babak Oleg Yakovich. Development a personalized correction hypertension with insulin resistance based on molecular genetic analysis and ATR2R1 and PPARgamma genes polymorphisms. (popup.stage: ). 3.Kharkov national medical university. № 0212U000574
1 documents found

Updated: 2026-03-22


Роздрукувати цю сторінку